Brief: Shanghai Bio-Heart Biological Technology Says Investor To Inject RMB155.6 Mln In Zhejiang Bioheart
Jan 2 (Reuters) - Shanghai Bio-heart Biological
Technology Co Ltd 2185.HK :
* INVESTOR AGREED TO INJECT RMB155.6 MILLION INTO ZHEJIANG
BIOHEART
Further company coverage: 2185.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Bio-heart Biological Technology
See all newsBrief: Shanghai Bio-Heart Biological Technology Says NMPA Approves Bioheart Bioabsorbable Drug-Eluting Stents
Brief: Shanghai Bio-Heart Biological Technology Says Iberis Rdn System Completes Registration In Vietnam
Brief: Shanghai Bio-Heart Biological Technology Says Iberis RDN System Completed Registration In Thailand
Brief: Shanghai Bio-Heart Biological Technology Says Iberis RDN System Completes Registration With MHRA In UK
Brief: Shanghai Bio-Heart Biological Technology's Controlling Shareholder Increases Shareholding